1-3 of 3
Kazuma Ohyashiki
Close
Sort by
Journal Articles

Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms

Clinical Trials & Observations
Yasuhito Nannya, Magnus Tobiasson, Shinya Sato, Elsa Bernard, Shigeki Ohtake, June Takeda, Maria Creignou, Lanying Zhao, Manabu Kusakabe, Yuhei Shibata, Nobuhiko Nakamura, Mizuki Watanabe, Nobuhiro Hiramoto, Yusuke Shiozawa, Yuichi Shiraishi, Hiroko Tanaka, Kenichi Yoshida, Nobuyuki Kakiuchi, Hideki Makishima, Masahiro Nakagawa, Kensuke Usuki, Mitsumasa Watanabe, Kazunori Imada, Hiroshi Handa, Masataka Taguchi, Toru Kiguchi, Kazuma Ohyashiki, Takayuki Ishikawa, Akifumi Takaori-Kondo, Hisashi Tsurumi, Senji Kasahara, Shigeru Chiba, Tomoki Naoe, Satoru Miyano, Elli Papaemanuil, Yasushi Miyazaki, Eva Hellström-Lindberg, Seishi Ogawa
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3624–3636.
https://doi.org/10.1182/bloodadvances.2022009564
Published: 2023
Includes: Supplemental data
Journal Articles

Induction of multiple myeloma bone marrow stromal cell apoptosis by inhibiting extracellular vesicle miR-10a secretion

Tomohiro Umezu, Satoshi Imanishi, Seiichiro Yoshizawa, Chiaki Kawana, Junko H. Ohyashiki, Kazuma Ohyashiki
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3228–3240.
https://doi.org/10.1182/bloodadvances.2019000403
Published: 2019
Includes: Supplemental data
Journal Articles

Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis

Tomohiro Umezu, Satoshi Imanishi, Kenko Azuma, Chiaki Kobayashi, Seiichiro Yoshizawa, Kazuma Ohyashiki, Junko H. Ohyashiki
Journal: Blood Advances
Blood Adv (2017) 1 (13): 812–823.
https://doi.org/10.1182/bloodadvances.2016003251
Published: 2017
Includes: Supplemental data